Odonate Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Odonate Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| The Effect of Tesetaxel on the QTc Interval and the Effect of Food, Itraconazole, and Rifampin on Tesetaxel Pharmacokinetics in Patients With Advanced Solid Tumors (NCT04312282) | Odonate Therapeutics, Inc. | 2020-03-06 |
| Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC (NCT03952325) | Odonate Therapeutics, Inc. | 2019-07-09 |
| Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC (NCT03858972) | Odonate Therapeutics, Inc. | 2019-02-05 |
| Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (NCT03326674) | Odonate Therapeutics, Inc. | 2017-12-21 |
Track Odonate Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.